Andrew Nelson

Andrew Nelson, MSRA, MS, is currently a Manager of Regulatory CMC Strategy for Vaccines at Pfizer, a position held since 2022. Prior to this role, Andrew worked as a Regulatory Senior Associate in Pfizer's vaccines portfolio from 2015 to 2017, where they assessed regulatory risks and contributed to the development of clinical trial and commercial licenses for various vaccine products, including the COVID-19 vaccine. They also have a history of analytical and technical work as an Associate Scientist, focusing on quality control and regulatory compliance for biologics. Andrew's earlier experience includes roles in laboratory settings, providing foundational support in the life sciences. Currently, Andrew is pursuing further education at the University of Florida, expected to conclude in 2025.